SlideShare a Scribd company logo
APPROACHTO
BLEEDING DISORDERS
PART- I
- Dr. Bidhan Chandra Nayak
- MD PGT, Department of Pathology,
- B.S. Medical College & Hospital
Part 1-
1) Normal coagulation homeostasis
2) Bleeding disorders- introduction & classification
3) Clinical evaluation of bleeding disorders
Part 2-
1) Lab investigations:-
I) Screening
A. Screening tests for primary hemostasis
B. Screening tests for secondary hemostasis
II) Specific tests
A. Tests for platelet functions
B. For coagulation factors
C. For fibrinolysis.
2) Different scenarios ~ Summary and conclusion
 Every human being has the same circulatory fluid ~ BLOOD.
 Blood flows within a closed system, in a fluid state ~ kept in fluidity by different factors.
 If this closed system, consisting of blood vessels, is injured  Blood tries to escape out of the vessels  to
prevent this, different regulatory mechanisms are activated to fill the gap with help of platelets,
coagulation factors & some other substances this process is k/a Hemostasis.
 In homeostasis this regulatory mechanism balances between factors promoting hemostasis (procoagulant)
and factors inhibiting hemostasis (anticoagulant).
 So, obviously there are 2 possible extreme abnormalities of this regulatory process  1) ed Procoagulant
&/or ed Anticoagulant activity resulting in hypercoagulability, 2) ed Procoagulant &/or ed Anticoagulant
activity resulting in ed propensity to bleed.
INTRODUCTION:-
Prevention of blood clotting in normal blood vessels :–
• The smoothness of vascular endothelium prevents platelet adhesion and contact
activation of intrinsic clotting cascade.
• A layer of Glycocalyx on endothelium repels platelets and intrinsic factor to contact .
• Protein bound to endothelium called Trombomodulin binds with Thrombin and slows
the process of clotting and their complex molecule “ Thrombomodulin-thrombin“
activates protein C , inhibits factor V and VIII.
• Anticoagulants are also present in blood itself ----They remove thrombin from the
blood.
Normal Coagulation Homeostasis
 Hemostasis is a precisely orchestrated process involving platelets, clotting
factors, and endothelium that occurs at the site of vascular injury and
culminates in the formation of a blood clot, which serves to prevent or limit the
extent of bleeding.
DEFINITION OF HEMOSTASIS:-
 Primary haemostasis involves the
binding of platelets to exposed
collagen in the sub endothelium of
damaged vessels.
 Secondary haemostasis is the process
of activation of coagulation factors
leading to the production of
thrombin.
7
(A)  After vascular injury, local neurohumoral
factors induce a transient vasoconstriction.
(B)  Platelets bind via glycoprotein Ib (GpIb)
receptors to von Willebrand factor (vWF) on exposed
extracellular matrix (ECM) and are activated,
undergoing a shape change and granule release.
Released ADP & thromboxane A2 (TxA2) induce
additional platelet aggregation through platelet
GpIIb-IIIa receptor binding to fibrinogen, and form
the primary hemostatic plug.
Platelet adhesion and aggregation-
Von Willebrand factor functions as an
adhesion bridge between subendothelial
collagen and the glycoprotein Ib (GpIb)
platelet receptor. Aggregation occurs by
fibrinogen bridging GpIIb-IIIa receptors on
different platelets.
Congenital deficiencies in the various
receptors or bridging molecules lead to
different diseases.
(C)  Local activation of the coagulation cascade
(involving tissue factor and platelet phospholipids) results
in fibrin polymerization, “cementing” the platelets into a
definitive secondary hemostatic plug.
(D)  Counterregulatory mechanisms, mediated by
tissue plasminogen activator (t-PA, a fibrinolytic product)
and thrombomodulin, confine the hemostatic process to
the site of injury
SIMPLIFIED DIAGRAM OF COAGULATION CASCADE:-
..COAGULATION CASCADE.. Cont’d. :-
Procoagulant & Anticoagulant factors
PROCOAGULANT FACTORS :-
PROCOAGULANT FACTORS.. Cont’d.. :-
ANTICOAGULANT FACTORS:-
Some Other Inhibitors of Coagulation:-
 α2 macroglobulin – It act as antithrombin, antiplasmin and inactivate kallikrein.
α2 antitrypsin ( alpha globulin) – Inhibitor of factor XIa and antiplasmin and is weakly antithrombin.
α2 antiplasmin – Inactivate plasmin.
Heparin – inhibit the action of thrombin - delay the interaction of thrombin and fibrinogen.
ANTICOAGULANTS..regulating the coagulation cascade:-
FIBRINOLYSIS:-
So, it’s all about a
finely tuned balance ~
regulating
Procoagulant,
Anticoagulant &
Fibrinolytic factors..
Bleeding disorders – Introduction &
Classification
Bleeding disorders can be due to
Blood vessel anomalies Platelet abnormalities Coagulation disorders
Disorders associated with abnormal bleeding inevitably stem from
primary or secondary defects in vessel walls, platelets, or coagulation
factors, all of which must function properly to ensure hemostasis.
HEREDITARY:-
1) Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease )
2) Ehler Danlos Syndrome
ALLERGIC:-
1) Henoch–Schönlein purpura (HSP)
2) Leucocytoclastic angitis
ATROPHIC:-
1) Senile purpura
2) Scurvy
MISCELLANEOUS:-
1) Simple easy bruising
2) Amyloidosis
3) Infections
DISORDERS OF VESSEL WALL:-
PLATELET
ABNORMALITIES
QUALITATIVE QUANTITATIVE
•THROMBASTHENIA
•BERNARD-SOULIER SYNDROME
•DRUGS(ASPIRIN,TXA2,INDOMETHACIN
•THROMBOCYTOPENIA
•THROMBOCYTHEMIA
PLATELET DISORDERS:-
PLATELET DISORDERS.. Cont’d:-
DISORDERS OF COAGULATION:-
INHERITED ACQUIRED
HEMOPHILIAA DIC
HEMOPHILIA B LIVER DISEASE
vWD HDN
DISORDERS OF FIBRINOGEN-
HEREDITARY AFIBRINOGENAEMIA
HYPOFIBRINOGENAEMIA
DYSFIBRINOGENAEMIA
Nephrotic Syndrome
FXIII deficiency APLS
FV deficiency HEPARIN OR ORAL ANTICOAGULANT
THERAPY
VIT K DEFICIENCY
MASSIVE TRANSFUSION OF STORED
BLOOD
COAGULATION FACTOR DEFICIENCIES:-
BLEEDING DISORDERS ~ Diagnostic
approach
Diagnosis of bleeding disorders ~ a stepwise approach ~
HISTORY
CLINICAL EXAMINATION
LABORATORY INVESTIGATIONS
BLEEDING DISORDERS - Clinical evaluation
~ A diagnostic tool
HISTORY:-
1)Age of first manifestation,
2)Family history of bleeding,
3)Spontaneous or after trauma,
4) Time of manifestation after injury,
5)Ease with which bleeding is controlled,
6) Drug history.
Clinical evaluation:-
INHERITED DISORDERS
• Early age of presentation
• Family history positive
• More severe
• Bleeding is the dominant feature
• Single factor defect
ACQUIRED DISORDERS
• Later age of presentation
• Family history usually negative
• Less severe
• Clinical picture is dominated by the
underlying disorder e.g.DIC
• Multiple hemostatic defect
Clinical evaluation.. Cont’d:-
HEREDITARY ACQUIRED
1) History of disorder only in males on the maternal
side for many generations – X linked recessive
Hemophilia A or B.
2) History of consanguineous marriage, both males
and females only from the current generation
affected –Autosomal recessive disorders like
afibrinogenemia, FactorV or Factor X deficiency,
vWD disease(Types 1 and 2 autosomal dominant
traits and type 3 autosomal recessive, type 2
Occasionally AR)
3) Bleeding in both males and females, bleeding in one
parent, bleeding in all generations – Autosomal
dominantdisorders like von willebrand disease,
hereditary hemorrhagic telengectasia
Usually secondary to disorders of
1. liver
2. uremia
3. hematologic malignancies
4. carcinoma
5. sepsis
Clinical evaluation.. Cont’d:-
Clinical evaluation.. Cont’d:-
Pinpoint purpura
Petechiae, Purpura and Ecchymoses are the three terms that refer to bleeding that occurs in the skin.
The term “petechiae” refers to smaller lesions. “Purpura” and “ecchymoses” are terms that refer to larger lesions.
Petechiae  <3 mm, Purpura 0.3–1 cm (3–10 mm), ecchymoses >1 cm.
Clinical evaluation.. Cont’d:-
ECCHYMOSES IN ARM
Findings Disorders of Platelet Disorders of Coagulation
i) Petechiae
ii) Superficial ecchymosis
iii) Deep dissecting hematomas
iv) Haemarthrosis
v) Bleeding from the superficial cuts &
scratches.
vi) Positive family history
vii) Bleeding from mucous membrane
viii) Sex-
Characteristic
Characteristic, usually
small & multiple
Rare
Rare
Persistent often profuse
Rare
Prominent
More common in females
Rare
Common, usually large & solitary
Characteristic
Characteristic
Minimal
Common
May occur
Inherited forms occur only in males
Clinical evaluation.. Cont’d:-
Clinical evaluation.. Cont’d:-
Clinical evaluation.. Cont’d:-
PALPABLE PURPURA:-
Mn- HoPe DREAM
Henoch-Schönlein purpura (HSP)
Polyarteritis Nodosa
Disseminated gonococcal infection
Rocky Mountain Spotted Fever
Ecthyma gangrenosum
Acute meningococcemia
Mixed cryoglobulinemia
Clinical evaluation.. Cont’d:-
Hemarthrosis in a case of Hemophilia Purpura in a case of ITP
Clinical evaluation.. Cont’d:-
Henoch–Schönlein purpura (HSP):- Typical purpura on lower limbs and buttocks
Clinical evaluation.. Cont’d:-
SCURVY – Easy bruising SCURVY – Gum bleeding
Thank you..

More Related Content

What's hot

Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
Manisha Meda
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Dr Sayan Das
 
Immune Thrombocytopenic Purpura
Immune Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
Nahar Kamrun
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
Princess Alen Aguilar-Cabunoc
 
Bleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and DiagnosisBleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and Diagnosis
Dr Medical
 
CME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical FeaturesCME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical Features
Stanley Medical College, Department of Medicine
 
Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
Ghie Santos
 
idiopathic thrombocytopinic purpura
idiopathic thrombocytopinic purpuraidiopathic thrombocytopinic purpura
idiopathic thrombocytopinic purpura
dr yogendra vijay
 
Platelet disorder with ITP
Platelet disorder with ITPPlatelet disorder with ITP
Platelet disorder with ITP
Nahar Kamrun
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
raj kumar
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Sachin Giri
 
Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders
Rakesh Verma
 
Idiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
Dr. Aryan (Anish Dhakal)
 
Blood Transfusion
Blood TransfusionBlood Transfusion
Blood Transfusion
MD Specialclass
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
Rajesh S
 
Bleeding Disorders: Causes, Types, and Diagnosis
Bleeding Disorders: Causes, Types, and Diagnosis Bleeding Disorders: Causes, Types, and Diagnosis
Bleeding Disorders: Causes, Types, and Diagnosis
Dr Medical
 
Polycythemia vera
Polycythemia vera Polycythemia vera
Polycythemia vera
М. Лхагва-Өлзий
 
Idiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic PurpuraIdiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic Purpura
Dr. Saad Saleh Al Ani
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
Diana Girnita
 
Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
DR. JITHIN GEORGE
 

What's hot (20)

Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Immune Thrombocytopenic Purpura
Immune Thrombocytopenic PurpuraImmune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
 
Platelet disorders
Platelet disordersPlatelet disorders
Platelet disorders
 
Bleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and DiagnosisBleeding disorders Causes, Types, and Diagnosis
Bleeding disorders Causes, Types, and Diagnosis
 
CME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical FeaturesCME: Bleeding Disorders - Clinical Features
CME: Bleeding Disorders - Clinical Features
 
Coagulation Disorders
Coagulation DisordersCoagulation Disorders
Coagulation Disorders
 
idiopathic thrombocytopinic purpura
idiopathic thrombocytopinic purpuraidiopathic thrombocytopinic purpura
idiopathic thrombocytopinic purpura
 
Platelet disorder with ITP
Platelet disorder with ITPPlatelet disorder with ITP
Platelet disorder with ITP
 
Bleeding disorders
Bleeding disordersBleeding disorders
Bleeding disorders
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders Bleeding and Thrombotic Disorders
Bleeding and Thrombotic Disorders
 
Idiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic PurpuraIdiopathic Thrombocytopenic Purpura
Idiopathic Thrombocytopenic Purpura
 
Blood Transfusion
Blood TransfusionBlood Transfusion
Blood Transfusion
 
Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)Bleeding disorders(Disorders of Platelets and vessel wall)
Bleeding disorders(Disorders of Platelets and vessel wall)
 
Bleeding Disorders: Causes, Types, and Diagnosis
Bleeding Disorders: Causes, Types, and Diagnosis Bleeding Disorders: Causes, Types, and Diagnosis
Bleeding Disorders: Causes, Types, and Diagnosis
 
Polycythemia vera
Polycythemia vera Polycythemia vera
Polycythemia vera
 
Idiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic PurpuraIdiopathic (autoimmune) Thrombocytopenic Purpura
Idiopathic (autoimmune) Thrombocytopenic Purpura
 
Thrombocytopenia
ThrombocytopeniaThrombocytopenia
Thrombocytopenia
 
Disorders of platelets
Disorders of plateletsDisorders of platelets
Disorders of platelets
 

Similar to Approach to bleeding disorders part 1

Hemorrhagic Syndromes
Hemorrhagic SyndromesHemorrhagic Syndromes
Hemorrhagic Syndromes
Shubham Patil
 
Coagulation dirorder 2021
Coagulation dirorder 2021Coagulation dirorder 2021
Coagulation dirorder 2021
aljamhori teaching hospital
 
Platelet and coagulation post graduate lecture
Platelet and coagulation post graduate lecture  Platelet and coagulation post graduate lecture
Platelet and coagulation post graduate lecture
Monkez M Yousif
 
Hemostatsis & blood transfusion
Hemostatsis & blood transfusionHemostatsis & blood transfusion
Hemostatsis & blood transfusion
ABDUL QADEER MEMON
 
L15xL17.pptx
L15xL17.pptxL15xL17.pptx
L15xL17.pptx
xgone
 
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSISCIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
Dr. Roopam Jain
 
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSISCIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
Dr. Roopam Jain
 
platelets disorders
platelets disordersplatelets disorders
THROMBOSIS
THROMBOSISTHROMBOSIS
THROMBOSIS
Dr. Roopam Jain
 
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERSNORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
AmosiRichard
 
ADVANCE PHARMACOLOGY presentation
ADVANCE PHARMACOLOGY presentationADVANCE PHARMACOLOGY presentation
ADVANCE PHARMACOLOGY presentation
SIMRAN VERMA
 
Anti thrombiotic therapy
Anti thrombiotic therapy Anti thrombiotic therapy
Anti thrombiotic therapy
Santhi Dasari
 
Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)
Santhi Dasari
 
Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)
Tamil Jothi
 
GIẢM TIỂU CẦU - HỘI CHỨNG HELLP
GIẢM TIỂU CẦU - HỘI CHỨNG HELLPGIẢM TIỂU CẦU - HỘI CHỨNG HELLP
GIẢM TIỂU CẦU - HỘI CHỨNG HELLP
SoM
 
Hemorrhagic disorders march 2020
Hemorrhagic disorders  march 2020Hemorrhagic disorders  march 2020
Hemorrhagic disorders march 2020
Micheal Mikael
 
4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx
MohammadKhan656704
 
Seminar on hemostatsis
Seminar on hemostatsisSeminar on hemostatsis
Seminar on hemostatsis
aasthakadiyan
 
Blood Coagulation , ABO blood group & Rh factor
Blood Coagulation , ABO blood group & Rh factorBlood Coagulation , ABO blood group & Rh factor
Blood Coagulation , ABO blood group & Rh factor
SusmitaShaw3
 
Blood coagulation
Blood coagulationBlood coagulation
Blood coagulation
Vernon Pashi
 

Similar to Approach to bleeding disorders part 1 (20)

Hemorrhagic Syndromes
Hemorrhagic SyndromesHemorrhagic Syndromes
Hemorrhagic Syndromes
 
Coagulation dirorder 2021
Coagulation dirorder 2021Coagulation dirorder 2021
Coagulation dirorder 2021
 
Platelet and coagulation post graduate lecture
Platelet and coagulation post graduate lecture  Platelet and coagulation post graduate lecture
Platelet and coagulation post graduate lecture
 
Hemostatsis & blood transfusion
Hemostatsis & blood transfusionHemostatsis & blood transfusion
Hemostatsis & blood transfusion
 
L15xL17.pptx
L15xL17.pptxL15xL17.pptx
L15xL17.pptx
 
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSISCIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE - THROMBOSIS
 
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSISCIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
CIRCULATORY DISTURBANCES OF OBSTRUCTIVE NATURE: THROMBOSIS
 
platelets disorders
platelets disordersplatelets disorders
platelets disorders
 
THROMBOSIS
THROMBOSISTHROMBOSIS
THROMBOSIS
 
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERSNORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
NORMAL HEMOSTASIS, PLATELET AND VASCULAR DISORDERS
 
ADVANCE PHARMACOLOGY presentation
ADVANCE PHARMACOLOGY presentationADVANCE PHARMACOLOGY presentation
ADVANCE PHARMACOLOGY presentation
 
Anti thrombiotic therapy
Anti thrombiotic therapy Anti thrombiotic therapy
Anti thrombiotic therapy
 
Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)
 
Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)Anti thrombiotic therapy (1)
Anti thrombiotic therapy (1)
 
GIẢM TIỂU CẦU - HỘI CHỨNG HELLP
GIẢM TIỂU CẦU - HỘI CHỨNG HELLPGIẢM TIỂU CẦU - HỘI CHỨNG HELLP
GIẢM TIỂU CẦU - HỘI CHỨNG HELLP
 
Hemorrhagic disorders march 2020
Hemorrhagic disorders  march 2020Hemorrhagic disorders  march 2020
Hemorrhagic disorders march 2020
 
4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx4. hemostasis, bleeding & BT.pptx
4. hemostasis, bleeding & BT.pptx
 
Seminar on hemostatsis
Seminar on hemostatsisSeminar on hemostatsis
Seminar on hemostatsis
 
Blood Coagulation , ABO blood group & Rh factor
Blood Coagulation , ABO blood group & Rh factorBlood Coagulation , ABO blood group & Rh factor
Blood Coagulation , ABO blood group & Rh factor
 
Blood coagulation
Blood coagulationBlood coagulation
Blood coagulation
 

Recently uploaded

Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero WaterSharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Texas Alliance of Groundwater Districts
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
by6843629
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
University of Maribor
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
KrushnaDarade1
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
Sciences of Europe
 
molar-distalization in orthodontics-seminar.pptx
molar-distalization in orthodontics-seminar.pptxmolar-distalization in orthodontics-seminar.pptx
molar-distalization in orthodontics-seminar.pptx
Anagha Prasad
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
Sérgio Sacani
 
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
AbdullaAlAsif1
 
Immersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths ForwardImmersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths Forward
Leonel Morgado
 
The debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically youngThe debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically young
Sérgio Sacani
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
MAGOTI ERNEST
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
vluwdy49
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
HongcNguyn6
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
RitabrataSarkar3
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
European Sustainable Phosphorus Platform
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
İsa Badur
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
IshaGoswami9
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
hozt8xgk
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
terusbelajar5
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
muralinath2
 

Recently uploaded (20)

Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero WaterSharlene Leurig - Enabling Onsite Water Use with Net Zero Water
Sharlene Leurig - Enabling Onsite Water Use with Net Zero Water
 
8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf8.Isolation of pure cultures and preservation of cultures.pdf
8.Isolation of pure cultures and preservation of cultures.pdf
 
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
Remote Sensing and Computational, Evolutionary, Supercomputing, and Intellige...
 
SAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdfSAR of Medicinal Chemistry 1st by dk.pdf
SAR of Medicinal Chemistry 1st by dk.pdf
 
Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)Sciences of Europe journal No 142 (2024)
Sciences of Europe journal No 142 (2024)
 
molar-distalization in orthodontics-seminar.pptx
molar-distalization in orthodontics-seminar.pptxmolar-distalization in orthodontics-seminar.pptx
molar-distalization in orthodontics-seminar.pptx
 
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
EWOCS-I: The catalog of X-ray sources in Westerlund 1 from the Extended Weste...
 
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
Unlocking the mysteries of reproduction: Exploring fecundity and gonadosomati...
 
Immersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths ForwardImmersive Learning That Works: Research Grounding and Paths Forward
Immersive Learning That Works: Research Grounding and Paths Forward
 
The debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically youngThe debris of the ‘last major merger’ is dynamically young
The debris of the ‘last major merger’ is dynamically young
 
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptxThe use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
The use of Nauplii and metanauplii artemia in aquaculture (brine shrimp).pptx
 
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
在线办理(salfor毕业证书)索尔福德大学毕业证毕业完成信一模一样
 
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốtmô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
mô tả các thí nghiệm về đánh giá tác động dòng khí hóa sau đốt
 
Eukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptxEukaryotic Transcription Presentation.pptx
Eukaryotic Transcription Presentation.pptx
 
Thornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdfThornton ESPP slides UK WW Network 4_6_24.pdf
Thornton ESPP slides UK WW Network 4_6_24.pdf
 
aziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobelaziz sancar nobel prize winner: from mardin to nobel
aziz sancar nobel prize winner: from mardin to nobel
 
Phenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvementPhenomics assisted breeding in crop improvement
Phenomics assisted breeding in crop improvement
 
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
快速办理(UAM毕业证书)马德里自治大学毕业证学位证一模一样
 
Medical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptxMedical Orthopedic PowerPoint Templates.pptx
Medical Orthopedic PowerPoint Templates.pptx
 
Oedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptxOedema_types_causes_pathophysiology.pptx
Oedema_types_causes_pathophysiology.pptx
 

Approach to bleeding disorders part 1

  • 1. APPROACHTO BLEEDING DISORDERS PART- I - Dr. Bidhan Chandra Nayak - MD PGT, Department of Pathology, - B.S. Medical College & Hospital
  • 2. Part 1- 1) Normal coagulation homeostasis 2) Bleeding disorders- introduction & classification 3) Clinical evaluation of bleeding disorders Part 2- 1) Lab investigations:- I) Screening A. Screening tests for primary hemostasis B. Screening tests for secondary hemostasis II) Specific tests A. Tests for platelet functions B. For coagulation factors C. For fibrinolysis. 2) Different scenarios ~ Summary and conclusion
  • 3.  Every human being has the same circulatory fluid ~ BLOOD.  Blood flows within a closed system, in a fluid state ~ kept in fluidity by different factors.  If this closed system, consisting of blood vessels, is injured  Blood tries to escape out of the vessels  to prevent this, different regulatory mechanisms are activated to fill the gap with help of platelets, coagulation factors & some other substances this process is k/a Hemostasis.  In homeostasis this regulatory mechanism balances between factors promoting hemostasis (procoagulant) and factors inhibiting hemostasis (anticoagulant).  So, obviously there are 2 possible extreme abnormalities of this regulatory process  1) ed Procoagulant &/or ed Anticoagulant activity resulting in hypercoagulability, 2) ed Procoagulant &/or ed Anticoagulant activity resulting in ed propensity to bleed. INTRODUCTION:-
  • 4. Prevention of blood clotting in normal blood vessels :– • The smoothness of vascular endothelium prevents platelet adhesion and contact activation of intrinsic clotting cascade. • A layer of Glycocalyx on endothelium repels platelets and intrinsic factor to contact . • Protein bound to endothelium called Trombomodulin binds with Thrombin and slows the process of clotting and their complex molecule “ Thrombomodulin-thrombin“ activates protein C , inhibits factor V and VIII. • Anticoagulants are also present in blood itself ----They remove thrombin from the blood.
  • 6.  Hemostasis is a precisely orchestrated process involving platelets, clotting factors, and endothelium that occurs at the site of vascular injury and culminates in the formation of a blood clot, which serves to prevent or limit the extent of bleeding. DEFINITION OF HEMOSTASIS:-
  • 7.  Primary haemostasis involves the binding of platelets to exposed collagen in the sub endothelium of damaged vessels.  Secondary haemostasis is the process of activation of coagulation factors leading to the production of thrombin. 7
  • 8.
  • 9. (A)  After vascular injury, local neurohumoral factors induce a transient vasoconstriction. (B)  Platelets bind via glycoprotein Ib (GpIb) receptors to von Willebrand factor (vWF) on exposed extracellular matrix (ECM) and are activated, undergoing a shape change and granule release. Released ADP & thromboxane A2 (TxA2) induce additional platelet aggregation through platelet GpIIb-IIIa receptor binding to fibrinogen, and form the primary hemostatic plug.
  • 10. Platelet adhesion and aggregation- Von Willebrand factor functions as an adhesion bridge between subendothelial collagen and the glycoprotein Ib (GpIb) platelet receptor. Aggregation occurs by fibrinogen bridging GpIIb-IIIa receptors on different platelets. Congenital deficiencies in the various receptors or bridging molecules lead to different diseases.
  • 11. (C)  Local activation of the coagulation cascade (involving tissue factor and platelet phospholipids) results in fibrin polymerization, “cementing” the platelets into a definitive secondary hemostatic plug. (D)  Counterregulatory mechanisms, mediated by tissue plasminogen activator (t-PA, a fibrinolytic product) and thrombomodulin, confine the hemostatic process to the site of injury
  • 12. SIMPLIFIED DIAGRAM OF COAGULATION CASCADE:-
  • 14.
  • 15.
  • 19. ANTICOAGULANT FACTORS:- Some Other Inhibitors of Coagulation:-  α2 macroglobulin – It act as antithrombin, antiplasmin and inactivate kallikrein. α2 antitrypsin ( alpha globulin) – Inhibitor of factor XIa and antiplasmin and is weakly antithrombin. α2 antiplasmin – Inactivate plasmin. Heparin – inhibit the action of thrombin - delay the interaction of thrombin and fibrinogen.
  • 22. So, it’s all about a finely tuned balance ~ regulating Procoagulant, Anticoagulant & Fibrinolytic factors..
  • 23. Bleeding disorders – Introduction & Classification
  • 24. Bleeding disorders can be due to Blood vessel anomalies Platelet abnormalities Coagulation disorders Disorders associated with abnormal bleeding inevitably stem from primary or secondary defects in vessel walls, platelets, or coagulation factors, all of which must function properly to ensure hemostasis.
  • 25. HEREDITARY:- 1) Hereditary hemorrhagic telangiectasia (Osler–Weber–Rendu disease ) 2) Ehler Danlos Syndrome ALLERGIC:- 1) Henoch–Schönlein purpura (HSP) 2) Leucocytoclastic angitis ATROPHIC:- 1) Senile purpura 2) Scurvy MISCELLANEOUS:- 1) Simple easy bruising 2) Amyloidosis 3) Infections DISORDERS OF VESSEL WALL:-
  • 28. DISORDERS OF COAGULATION:- INHERITED ACQUIRED HEMOPHILIAA DIC HEMOPHILIA B LIVER DISEASE vWD HDN DISORDERS OF FIBRINOGEN- HEREDITARY AFIBRINOGENAEMIA HYPOFIBRINOGENAEMIA DYSFIBRINOGENAEMIA Nephrotic Syndrome FXIII deficiency APLS FV deficiency HEPARIN OR ORAL ANTICOAGULANT THERAPY VIT K DEFICIENCY MASSIVE TRANSFUSION OF STORED BLOOD
  • 30. BLEEDING DISORDERS ~ Diagnostic approach
  • 31. Diagnosis of bleeding disorders ~ a stepwise approach ~ HISTORY CLINICAL EXAMINATION LABORATORY INVESTIGATIONS
  • 32. BLEEDING DISORDERS - Clinical evaluation ~ A diagnostic tool
  • 33. HISTORY:- 1)Age of first manifestation, 2)Family history of bleeding, 3)Spontaneous or after trauma, 4) Time of manifestation after injury, 5)Ease with which bleeding is controlled, 6) Drug history. Clinical evaluation:-
  • 34. INHERITED DISORDERS • Early age of presentation • Family history positive • More severe • Bleeding is the dominant feature • Single factor defect ACQUIRED DISORDERS • Later age of presentation • Family history usually negative • Less severe • Clinical picture is dominated by the underlying disorder e.g.DIC • Multiple hemostatic defect Clinical evaluation.. Cont’d:-
  • 35. HEREDITARY ACQUIRED 1) History of disorder only in males on the maternal side for many generations – X linked recessive Hemophilia A or B. 2) History of consanguineous marriage, both males and females only from the current generation affected –Autosomal recessive disorders like afibrinogenemia, FactorV or Factor X deficiency, vWD disease(Types 1 and 2 autosomal dominant traits and type 3 autosomal recessive, type 2 Occasionally AR) 3) Bleeding in both males and females, bleeding in one parent, bleeding in all generations – Autosomal dominantdisorders like von willebrand disease, hereditary hemorrhagic telengectasia Usually secondary to disorders of 1. liver 2. uremia 3. hematologic malignancies 4. carcinoma 5. sepsis Clinical evaluation.. Cont’d:-
  • 36. Clinical evaluation.. Cont’d:- Pinpoint purpura Petechiae, Purpura and Ecchymoses are the three terms that refer to bleeding that occurs in the skin. The term “petechiae” refers to smaller lesions. “Purpura” and “ecchymoses” are terms that refer to larger lesions. Petechiae  <3 mm, Purpura 0.3–1 cm (3–10 mm), ecchymoses >1 cm.
  • 38. Findings Disorders of Platelet Disorders of Coagulation i) Petechiae ii) Superficial ecchymosis iii) Deep dissecting hematomas iv) Haemarthrosis v) Bleeding from the superficial cuts & scratches. vi) Positive family history vii) Bleeding from mucous membrane viii) Sex- Characteristic Characteristic, usually small & multiple Rare Rare Persistent often profuse Rare Prominent More common in females Rare Common, usually large & solitary Characteristic Characteristic Minimal Common May occur Inherited forms occur only in males Clinical evaluation.. Cont’d:-
  • 40. Clinical evaluation.. Cont’d:- PALPABLE PURPURA:- Mn- HoPe DREAM Henoch-Schönlein purpura (HSP) Polyarteritis Nodosa Disseminated gonococcal infection Rocky Mountain Spotted Fever Ecthyma gangrenosum Acute meningococcemia Mixed cryoglobulinemia
  • 41. Clinical evaluation.. Cont’d:- Hemarthrosis in a case of Hemophilia Purpura in a case of ITP
  • 42. Clinical evaluation.. Cont’d:- Henoch–Schönlein purpura (HSP):- Typical purpura on lower limbs and buttocks
  • 43. Clinical evaluation.. Cont’d:- SCURVY – Easy bruising SCURVY – Gum bleeding